Trump Administration Files Amicus Brief Siding with Pharma Against 340B in Louisiana Federal Case
Issue
The US government filed an amicus brief in a Louisiana federal 340B case siding with pharmaceutical manufacturers, arguing states cannot enforce 340B contract pharmacy protections. Combined with a Fourth Circuit ruling blocking West Virginia's 340B law, this signals coordinated erosion of state-level 340B protections that could cost CA FQHCs millions in drug discount revenue.
Sources for this story
National Law ReviewSources for your board packet
This story's source plus 4 related stories and their sources, ready to print for your team or board.
Free. Unlocking the packet subscribes you to Intel Brief. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.
Part of
- 340B drug pricing
State contract-pharmacy laws and the circuit split
FQHC Talent. (2026, April 4). Trump Administration Files Amicus Brief Siding with Pharma Against 340B in Louisiana Federal Case. Source: National Law Review. Retrieved October 6, 2026, from https://www.fqhctalent.com/intel/us-amicus-brief-pharma-louisiana-340b